Consensus Artivion, Inc.

Stocks

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 23:00:02 11/09/2026 +03			5-day change	1st Jan Change
25.08 ^USD	+1.74%		-1.92%	-45.01%

09-12	Artivion Insider Sold Shares Worth $286,656, According to a Recent SEC Filing	MT
08-20	Artivion Insider Sold Shares Worth $2,026,850, According to a Recent SEC Filing	MT

Evolution of the Average Target: Artivion, Inc.

Evolution of the Target Price: Artivion, Inc.

Changes in Analyst Recommendations: Artivion, Inc.

5c3f0839684465f8d3b3f71d01ed.-7JSz4w6QXjjxIU14VkjZ1znwLCmQtVJ5uyeR5riZQo.l90VuOZVdQmih-ZltGFrDhOX84Dsc4UZ0YjmFe3XDj299Wul4wMeN7SMvQ~defe7dbe60d9a61cffc45d4d9b5f869d

Analysts' recommendations: Artivion, Inc.

22/08/25	Needham Raises Price Target on Artivion to $50 From $45, Keeps Buy Rating	MT
08/08/25	Artivion Q2 revenue up 15%, beats analyst expectations	RE
08/11/24	Oppenheimer Raises Artivion Price Target to $32 From $30, Maintains Outperform Rating	MT
23/10/24	JMP Securities Initiates Artivion at Outperform With $33 Price Target	MT
09/08/24	Oppenheimer Adjusts Artivion Price Target to $30 From $25, Maintains Outperform Rating	MT
02/07/24	Lake Street Raises Price Target on Artivion to $30 From $28, Maintains Buy Rating	MT
07/05/24	Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating	MT
07/05/24	Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating	MT
16/02/24	Stifel Raises Price Target on Artivion to $22 From $20, Maintains Buy Rating	MT
08/05/23	Morgan Stanley Adjusts Price Target on Artivion to $15 From $14, Maintains Equal-Weight Rating	MT
05/05/23	Needham Adjusts Price Target on Artivion to $26 From $23, Maintains Buy Rating	MT
04/11/22	Needham Adjusts Price Target on Artivion to $23 From $28, Maintains Buy Rating	MT
11/10/22	Morgan Stanley Trims Artivion's Price Target to $14 From $16, Reiterates Equalweight Rating	MT
27/09/22	Oppenheimer Adjusts Artivion's Price Target to $25 From $35, Maintains Outperform Rating	MT
26/09/22	Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating	MT
26/09/22	Oppenheimer Adjusts Artivion Price Target to $25 From $35, Maintains Outperform Rating	MT
05/08/22	Needham Trims Artivion's Price Target to $28 From $29, Reiterates Buy Rating	MT
15/07/22	Morgan Stanley Adjusts Artivion's Price Target to $21 from $23, Keeps Equalweight Rating	MT
06/05/22	Needham Trims Artivion's Price Target to $29 From $30, Reiterates Buy Rating	MT
03/03/22	Stifel Starts Artivion at Buy With $30 Price Target	MT
18/02/22	Needham Adjusts Artivion's Price Target to $30 From $39 on 'Peer Multiple Compression;' Buy Rating Kept	MT
07/01/22	Morgan Stanley Lowers Price Target for CryoLife to $25 From $29, Maintains Equalweight Rating	MT
30/07/21	CryoLife : Needham Adjusts CryoLife's Price Target to $39 From $38, Maintains Buy Rating	MT
15/07/21	CryoLife : Morgan Stanley Starts CryoLife at Equal-Weight With $31 Price Target	MT
30/04/21	CryoLife : Oppenheimer Adjusts CryoLife PT to $35 From $29, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ARTIVION, INC.					+68.06%
	ABBOTT LABORATORIES					+17.96%
	MEDTRONIC PLC					+15.17%
	CENCORA, INC.					+14.85%
	HOYA CORPORATION					+34.86%
	BECTON, DICKINSON AND COMPANY					+10.02%
	DEXCOM, INC.					+13.36%
	MEDLINE INC.					+37.1%
	WEST PHARMACEUTICAL SERVICES, INC.					+17.08%
	TERUMO CORPORATION					+39.84%
	Average					+26.83%
	Weighted average by Cap.					+19.48%